This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Source: OpenUrlAbstract/FREE Full Text
Investigators from multiple institutions in Australia conducted a prospective cohort study comparing clinical features, management, and outcomes in children with a first febrile seizure (FS) occurring soon after vaccination (vaccine-proximate febrile seizure [VP-FS]) and those with a nonvaccine-proximate febrile seizure (NVP-FS). Study participants were children <6 years old presenting to 1 of 5 hospitals in Australia between May 2013 and June 2014 with a first seizure associated with a temperature >38°C; patients with preexisting neurologic conditions and those with a central nervous system infection were excluded. Children with an FS occurring within 2 days after receiving inactivated vaccine, 5–14 days after receiving a live-attenuated vaccine, or 0–14 days after receiving a combination live and inactivated vaccine were classified …
Individual Login
Institutional Login
You may be able to gain access using your login credentials for your institution. Contact your librarian or administrator if you do not have a username and password.
Log in through your institution
Pay Per Article - You may access this article (from the computer you are currently using) for 2 days for US$25.00
Regain Access - You can regain access to a recent Pay per Article purchase if your access period has not yet expired.
In this issue
Related Articles
Cited By...
- No citing articles found.